PubRank

C A Schmidt

Author PubWeight™ 62.74‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Patterns of transcription of human cytomegalovirus in permissively infected cells. J Virol 1980 3.08
2 Comparative inactivation of viruses by chlorine. Appl Environ Microbiol 1980 2.04
3 Different real-time PCR formats compared for the quantitative detection of human cytomegalovirus DNA. Clin Chem 1999 1.77
4 COGENT (COlorectal cancer GENeTics): an international consortium to study the role of polymorphic variation on the risk of colorectal cancer. Br J Cancer 2009 1.62
5 Detection of herpesvirus type 6 by polymerase chain reaction in blood donors: random tests and prospective longitudinal studies. Br J Haematol 1994 1.53
6 Disruption of the BCL11B gene through inv(14)(q11.2q32.31) results in the expression of BCL11B-TRDC fusion transcripts and is associated with the absence of wild-type BCL11B transcripts in T-ALL. Leukemia 2005 1.39
7 Altered catalytic activity of and DNA cleavage by DNA topoisomerase II from human leukemic cells selected for resistance to VM-26. Biochemistry 1988 1.38
8 Prospective randomized trial to assess the value of preemptive oral therapy for CMV infection following liver transplantation. Transplantation 2001 1.38
9 Highly sensitive and specific fluorescence reverse transcription-PCR assay for the pseudogene-free detection of beta-actin transcripts as quantitative reference. Clin Chem 1999 1.35
10 Early serodiagnosis of acute human cytomegalovirus infection by enzyme-linked immunosorbent assay using recombinant antigens. J Clin Microbiol 1994 1.29
11 LightCycler technology for the quantitation of bcr/abl fusion transcripts. Cancer Res 1999 1.27
12 Detection of human cytomegalovirus DNA by real-time quantitative PCR. J Clin Microbiol 2000 1.24
13 Impalement injuries to the thorax as a result of motor vehicle accidents. Ann Thorac Surg 1987 1.24
14 Expression of axl, a transforming receptor tyrosine kinase, in normal and malignant hematopoiesis. Blood 1994 1.20
15 Quantitative analysis of beta-actin, beta-2-microglobulin and porphobilinogen deaminase mRNA and their comparison as control transcripts for RT-PCR. Mol Cell Probes 2002 1.20
16 Inhibition of BCL11B expression leads to apoptosis of malignant but not normal mature T cells. Oncogene 2006 1.08
17 Tumor suppressor TNFAIP3 (A20) is frequently deleted in Sézary syndrome. Leukemia 2011 0.99
18 Platypnea-orthodeoxia as a cause of unexplained hypoxemia in an 82-yr-old female. Cathet Cardiovasc Diagn 1990 0.95
19 Cardiopulmonary bypass in patients with heparin-induced thrombocytopenia and thrombosis. Ann Thorac Surg 2000 0.94
20 Herpesvirus type 6 in patients undergoing bone marrow transplantation: serologic features and detection by polymerase chain reaction. Blood 1994 0.94
21 A potential role for human herpesvirus type 6 in nervous system disease. J Neuroimmunol 1994 0.93
22 Distinct expression patterns of the p53-homologue p73 in malignant and normal hematopoiesis assessed by a novel real-time reverse transcription-polymerase chain reaction assay and protein analysis. Cancer Res 1999 0.92
23 Enhanced p73 expression during differentiation and complex p73 isoforms in myeloid leukemia. Biochem Biophys Res Commun 2000 0.92
24 Decreased DNA topoisomerase II in daunorubicin-resistant Ehrlich ascites tumor cells. Cancer Res 1991 0.92
25 Regulation of the nuclear proteasome activity in myelomonocytic human leukemia cells after adriamycin treatment. Blood 2001 0.89
26 Opioid receptor density changes in Alzheimer amygdala and putamen. Brain Res 1993 0.89
27 Long-term follow-up of hepatitis B virus-infected recipients after orthotopic liver transplantation. Transplantation 1994 0.87
28 Genetic alterations in the p53 gene in the blast crisis of chronic myelogenous leukemia: analysis by polymerase chain reaction based techniques. Leukemia 1993 0.87
29 Identification of human cytomegalovirus variants by analysis of single strand conformation polymorphism and DNA sequencing of the envelope glycoprotein B gene region-distribution frequency in liver transplant recipients. J Virol Methods 1999 0.87
30 Human herpesvirus type 7 in blood donors: detection by the polymerase chain reaction. J Med Virol 1995 0.86
31 Elevated p21 mRNA level in skeletal muscle of DMD patients and mdx mice indicates either an exhausted satellite cell pool or a higher p21 expression in dystrophin-deficient cells per se. J Mol Med (Berl) 2000 0.84
32 Subcellular distribution of the alpha and beta topoisomerase II-DNA complexes stabilized by VM-26. Biochem Pharmacol 1994 0.84
33 Molecular quantification of response to therapy and remission status in TEL-AML1-positive childhood ALL by real-time reverse transcription polymerase chain reaction. Cancer Res 2001 0.84
34 Applicability of an absolute quantitative procedure to monitor intra-individual bcr/abl transcript kinetics in clinical samples from chronic myelogenous leukemia patients. Int J Cancer 2000 0.83
35 Association of cytokeratin p39 with DNA in intact Novikoff hepatoma cells. Proc Natl Acad Sci U S A 1984 0.83
36 Hepatocytes are permissive for human cytomegalovirus infection in human liver cell culture and In vivo. J Infect Dis 1999 0.83
37 Quality assurance in RT-PCR-based BCR/ABL diagnostics--results of an interlaboratory test and a standardization approach. Leukemia 2000 0.83
38 Phase I trial of gemcitabine (Gemzar), 24 h infusion 5-fluorouracil and folinic acid in patients with inoperable pancreatic cancer. Anticancer Drugs 1999 0.83
39 Fluorescent 5'-exonuclease assay for the absolute quantification of Wilms' tumour gene (WT1) mRNA: implications for monitoring human leukaemias. Br J Haematol 2001 0.82
40 Extramedullary manifestation of a donor-derived acute myeloid leukemia in a liver transplant patient. Leukemia 2004 0.82
41 Thoracic aortic injury. A ten-year experience. Arch Surg 1984 0.81
42 Cross-linking of Novikoff ascites hepatoma cytokeratin filaments. Biochemistry 1985 0.81
43 Selection of B-cell chronic lymphocytic leukemia cell variants by therapy with anti-CD20 monoclonal antibody rituximab. Exp Hematol 2001 0.80
44 Molecular characterization of illegitimate TCR delta gene rearrangements in acute myeloid leukaemia. Br J Haematol 1994 0.80
45 Treatment with ganciclovir and Ig for acute Epstein-Barr virus infection after allogeneic bone marrow transplantation. Blood 1993 0.79
46 Genetic characterization of the multidrug-resistant phenotype of VM-26-resistant human leukemic cells. Cancer Res 1989 0.78
47 Soluble interleukin 2 receptors in patients after bone marrow transplantation. Bone Marrow Transplant 1990 0.78
48 Nuclear matrix antigens in azo dye-induced primary rat hepatomas. Cancer Res 1984 0.78
49 Demonstration of chimerism after allogeneic bone marrow transplantation by polymerase chain reaction of Y-chromosome-specific nucleotide sequences--characterization of a new technical approach. Leukemia 1993 0.78
50 Altered DNA topoisomerase II in multidrug resistance. Cytotechnology 1993 0.78
51 Novel T-cell receptor delta gene rearrangement involving a recombining element located 2.6 kb 3' from the Vdelta2 gene segment. Leuk Res 2001 0.78
52 Bronchogenic cyst presenting subsequent to intrapleural rupture. West J Med 1981 0.78
53 Increased ATP requirement for activity of and complex formation by DNA topoisomerase II from human leukemic CCRF-CEM cells selected for resistance to teniposide. Cancer Commun 1989 0.78
54 Influence of DNA polymerases on quantitative PCR results using TaqMan probe format in the LightCycler instrument. Mol Cell Probes 2000 0.78
55 Differential expression of the oncoproteins c-myc and c-myb in human lymphoproliferative disorders. Eur J Cancer 1990 0.78
56 Remote asynergy detected by biplane transesophageal echocardiography during myocardial revascularization without cardiopulmonary bypass. Anesth Analg 1991 0.78
57 Simultaneous absolute quantification of target and control templates by real-time fluorescence reverse transcription-PCR using 4-(4'-dimethylaminophenylazo)benzoic acid as a dark quencher dye. Clin Chem 2001 0.77
58 Molecular alterations in a patient with Turcot's syndrome. Br J Cancer 1993 0.77
59 PCR-SSCP: nonradioisotopic detection with biotinylated primers and streptavidin-alkaline phosphatase conjugate. Biotechniques 1995 0.77
60 Decreased resistance to N,N-dimethylated anthracyclines in multidrug-resistant Friend erythroleukemia cells. Cancer Chemother Pharmacol 1993 0.77
61 Bullet fragment venous embolus to the heart: case report. J Trauma 1991 0.76
62 Routine applications of DNA fingerprinting with the oligonucleotide probe (CAC)5/(GTG)5. Clin Genet 1991 0.76
63 Detection of p53 mutations using nonradioactive SSCP analysis: p53 is not frequently mutated in myelodysplastic syndromes (MDS). Ann Hematol 1993 0.76
64 Induction of differentiation in Friend-erythroleukemia cells by aclacinomycin A: early transient decrease in c-myc and c-myb mRNA levels. Leukemia 1992 0.76
65 Preemptive therapy in CMV-antigen positive patients after liver transplantation--a prospective trial. Ann Transplant 1999 0.75
66 [Risks and prevention in orthotopic liver transplantation and persistent infection with hepatitis type B and type delta viruses]. Z Arztl Fortbild (Jena) 1992 0.75
67 Epstein-Barr virus DNA quantitation assessed by a real-time polymerase chain reaction in a case of Burkitt's lymphoma. Leuk Lymphoma 2001 0.75
68 [HIV infection caused by needle injury]. Dtsch Med Wochenschr 1987 0.75
69 Biological evaluation of recombinant human erythropoietin in pharmaceutical products. Braz J Med Biol Res 2003 0.75
70 Immunocytochemical detection of p21ras expression in fresh human leukaemic cells and cell lines. Blut 1989 0.75
71 Arteriovenous fistula in arterial reconstruction of the ischemic limb. Arch Surg 1983 0.75
72 Septal wall motion. Its significance on outcome of left ventricular scar resection. Arch Surg 1980 0.75
73 [Lung metastases of colorectal tumors: clinical background and development of care supply]. Radiologe 2004 0.75
74 Characterization of monoclonal antibodies to novikoff hepatoma cytokeratin antigen p39. Cancer Res 1984 0.75
75 Incidence and therapy of cytomegalovirus disease after liver transplantation. Transplant Proc 1993 0.75
76 [Recommendations for the diagnosis and therapy of cytomegalovirus infection after stem-cell transplantation. The Research Alliance on the Complications of Organ Transplantation due to Herpes Viruses]. Dtsch Med Wochenschr 1999 0.75
77 Primary human herpesvirus 6 infection in an adult. N Engl J Med 1993 0.75
78 [Prophylaxis of infection in neutropenic patients. Guidelines of the Working Party on Infections in Hematology and Oncology]. Dtsch Med Wochenschr 2000 0.75
79 [Epidemiology and interventional treatment strategies of infectious complications after allogenic stem-cell transplantation]. Dtsch Med Wochenschr 2001 0.75
80 Incorporation of bromophenol blue enhances visibility of polyacrylamide gels. Biotechniques 1997 0.75
81 Is preemptive therapy for CMV infection following liver transplantation superior to symptom-triggered treatment? Transplant Proc 2001 0.75
82 Cytomegalovirus disease after liver transplantation: diagnostics and therapy. Transplant Proc 1993 0.75
83 Minimal impact of CMV infection on long-term survival after liver transplantation. Transplant Proc 2002 0.75
84 Comparative evaluation of the human whole blood and human peripheral blood monocyte tests for pyrogens. Int J Pharm 2003 0.75
85 [Orthotopic liver transplantation in hepatic cirrhosis: on the problem of infection of the transplant with persistent hepatitis viruses]. Z Gastroenterol 1992 0.75